# A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy

> **NCT01521598** · PHASE2 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 128 (actual)

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** SKL11197
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01521598
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521598, "A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01521598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*